Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO
12:47pm, Friday, 25'th Apr 2025
Total Investment in the State to Exceed $1.4 Billion, 750 U.S. Jobs THOUSAND OAKS, Calif. , April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio man
Amgen (AMGN) Earnings Expected to Grow: Should You Buy?
11:09am, Thursday, 24'th Apr 2025
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
09:53am, Tuesday, 22'nd Apr 2025
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However, you don't necessarily have to sacrifice growth for safety.
Final Trades: Take-Two Interactive, Franco-Nevada, Amgen and the 10-Year Treasury
01:33pm, Monday, 21'st Apr 2025
The Investment Committee give you their top stocks to watch for the second half.
Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?
10:06am, Monday, 21'st Apr 2025
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Here's Why Amgen (AMGN) is a Strong Value Stock
10:40am, Friday, 18'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
08:56am, Thursday, 17'th Apr 2025
Equities are down this year because of Donald Trump's trade policies. The 47th U.S. president decided to impose steep tariffs on imported goods from most countries, although he has since significantly
Amgen: The Biotech That Knows How To Make Money
08:15am, Thursday, 17'th Apr 2025
Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio, with significant contributions from rare disease treatments and biosimilars. Financially robust, Amgen achi
4 High-Yield Dividend Dogs of the Dow Crushing 2025 and Still the Best Bets
07:44am, Wednesday, 16'th Apr 2025
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael Higgins.
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
Switzerland's Sandoz files antitrust lawsuit against Amgen in US
01:13am, Monday, 14'th Apr 2025
Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etan
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
10:30am, Friday, 11'th Apr 2025
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told
